Abstract-an increasingly aging population is presenting greater prevalence of people with diabetes, co-morbidities and the complications. Moreover, poor management of diabetes increases risk of complications. There is need to monitor these patients more closely to ensure optimum management. However current management is based on simple clinic based blood pressure and HbA1c readings, which prove insensitive to detect problems of lifestyle and habits. We therefore developed a platform that could be deployed to all diabetes patients to take daily blood pressure and blood glucose measurements that were sent automatically to the clinician. Data was reviewed after a two week monitoring period. Those that were deemed well controlled were asked to return the devices, which were cycled to the next patient. Others were asked to make an appointment with the clinician for review. 37% of patients required intervention. When stratified for risk using parameters from the EPR we found the greatest change in HbA1c in the low risk group, with the high risk group having little change. The greatest problem was denial in the recently diagnosed and lapse in others, resulting in poor adherence to medication and lifestyle.
I. INTRODUCTION
An increasingly aging population is presenting greater prevalence of people with diabetes. Along with comorbidities, if not properly managed, this leads to high risk of developing complications, including stroke, heart disease, peripheral vascular disease, amputation and blindness. Complications occur most frequently in the elderly with type 2, as this form is without obvious symptoms, and there is long term poor management. There is a critical need to monitor these patients to ensure correct management, through ensuring they adhere to therapy and determining when there is deterioration and a need to change therapy. It is also essential that comorbidities, especially blood pressure, are well controlled. The current approach to managing diabetes patients with type 2 is through periodic blood tests for HbA1c and blood pressure measured in the clinic. However these are notoriously poor indicators, HbA1c is insensitive to the problems of day to day management of the condition and a single blood pressure is unrepresentative of underlying hypertension. Complementary tests are required to determine poor self-management, and comprehensive platforms are needed to provide the clinician with all the parameters necessary to manage the conflicting needs of managing the complex patient, when it is more important to manage the complication than the diabetes.
II. CLINICAL APPROACH
The Reaction project was established in the UK to develop and evaluate a novel approach that could manage all patients with diabetes in a locality. Currently, all routine diabetes care management in the UK is based in primary care. This includes a six monthly check in the clinic for blood and blood pressure. In the Reaction project this was supplemented by the patient undertaking two weeks of daily self-monitoring of blood pressure and blood glucose. Patients were instructed in use of the sensors in the clinic, and then provided with a kit to take home and self-install, including a home gateway that sent all measurements automatically to the clinician.
Measurements were reviewed after two weeks of monitoring to determine the level of control and selfmanagement, although patients were flagged in the system if data did not arrive on a daily basis, and the clinician would contact to determine cause. Data was also flagged if it would cause significant concern.
Those deemed well controlled were asked to return the equipment to the clinic, which was then cycled to the next patient.
Those not well controlled were contacted and asked to make an appointment to see the clinician to review management and therapy, and were instructed to continue taking measurements. Monitoring would continue for a further two weeks, when the data was checked again. The cycle would repeat until control was established.
III. TECHNICAL APPROACH
We used a platform [1] that is based on standards to allow us to provide a wide variety of sensors to manage complex patients, and included blood pressure, blood glucose, weight, and pulse oximetry. We redesigned the sensors to be extremely simple to use, as this was a predominantly elderly population.
We also designed a gateway that was extremely easy to deploy so that it could be self-installed by all patients. It was
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Malcolm Clarke-IEEE Senior Member, Joanna Fursse, Hulya Gokalp, Urvashi Sharma, and Russell W. Jones based on GSM/GPRS for the WAN connection so that it was self-contained, and in this way it allows simple and rapid installation. The gateway included no user interface. The platform was low cost to produce and required little resource to deploy, and therefore could scale to the number of patients in the pilot. The design also allowed the gateway to be installed in an unobtrusive position, which was welcomed by patients. The sensors also had no user interface, other than a simple light to indicate correct transmission to the gateway. This made the sensors quick and easy to use, and simplified instruction on use, thereby allowing us to meet the object to provide monitoring to all patients without need for a visit to the home by a technician. It also removed the feeling of "technology" which was an important aspect for use with the elderly patients.
In addition to the clinician portal, we also provided a patient portal to allow patients to view their own data, submit information on diet and lifestyle, and be given links to websites that contained educational material.
IV. METHODS
200 patients were registered with diabetes at the health center. 166 patients were invited to take part in the study, 34 excluded for reasons such as dementia. At the time of writing, 107 (64%) had been monitored once during the study and 30 patients had been monitored on 2 occasions; the monitoring still continuing.
V. RESULTS

37% of patients were identified as needing intervention. This resulted in;
 Mean reduction in HbA1c of 3mmol/mol  Mean reduction in the Systolic of 5mmHG A risk stratification model was developed to rank the need for patients to have intervention. Three groups were identified;  22% Low risk  47% Medium risk  21% High risk For patients who had an intervention, reductions for each risk group were;  Low Risk -HbA1c of 9.5mmol/L, Systolic 18mmHG, 2mmHG  Medium Risk -HbA1c 5mmol/L, Systolic 11mmHG, Diastolic 0mmHG  High Risk -1mmol/L, Systolic 20mmHG, Diastolic 10mmHG Patients in the low risk group had fewer complications and therefore it was easier to achieve the desired change in comparison to the high risk group.
The main cause of intervention was the patient in denial resulting in poor compliance and poor control. The monitoring was found to be effective in helping the patient to confront the problem and establish good management. 51% of patients completed an online questionnaire. 88% of these felt the experience had been beneficial particularly when it came to discussing their condition with the clinical team.
Satisfaction with both the equipment and patient portal was high.
48% of patients used the patient portal, primarily to check data had arrived or to enter data in case of technical problems. Patients appreciated the feedback concerning their measurements and how to interpret the results. Only 4% reported they had used it to view the educational content.
The clinicians were highly satisfied. They found it helped identify patients in need of intervention, engage patients in managing their condition, support clinical decision making and improve control and compliance.
The home monitoring equipment was successfully selfinstalled by 93% of patients. This drastically reduced time and cost over current home monitoring platforms and supported the new approach to diabetes management in this project.
The clinical portal was deemed good for reviewing patient data but where other EPR exist there needs to be greater integration to avoid duplication of data entry.
VI. CONCLUSION
The Reaction platform has supported a new approach to the management of diabetes in primary care. This includes collecting data from remote monitoring equipment, the patient portal and the EPR to create a comprehensive diabetes data management system. New workflows have been developed to support clinical management and diabetes management plans have been introduced that can be viewed either on paper or via the patient portal.
The monitoring has identified patients with greatest need of medical intervention and to target resources where required. The platform has provided educational feedback to support patient self-management, protection against diabetic complications and promote pro-active disease management.
